NM_001257.5:c.366+142T>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001257.5(CDH13):​c.366+142T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.54 in 650,656 control chromosomes in the GnomAD database, including 96,200 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.54 ( 22360 hom., cov: 32)
Exomes 𝑓: 0.54 ( 73840 hom. )

Consequence

CDH13
NM_001257.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0690

Publications

4 publications found
Variant links:
Genes affected
CDH13 (HGNC:1753): (cadherin 13) This gene encodes a member of the cadherin superfamily. The encoded protein is localized to the surface of the cell membrane and is anchored by a GPI moiety, rather than by a transmembrane domain. The protein lacks the cytoplasmic domain characteristic of other cadherins, and so is not thought to be a cell-cell adhesion glycoprotein. This protein acts as a negative regulator of axon growth during neural differentiation. It also protects vascular endothelial cells from apoptosis due to oxidative stress, and is associated with resistance to atherosclerosis. The gene is hypermethylated in many types of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-83032360-T-A is Benign according to our data. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-83032360-T-A is described in CliVar as Benign. Clinvar id is 1244376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.559 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH13NM_001257.5 linkc.366+142T>A intron_variant Intron 3 of 13 ENST00000567109.6 NP_001248.1 P55290-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH13ENST00000567109.6 linkc.366+142T>A intron_variant Intron 3 of 13 1 NM_001257.5 ENSP00000479395.1 P55290-1

Frequencies

GnomAD3 genomes
AF:
0.541
AC:
82177
AN:
151900
Hom.:
22327
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.524
Gnomad AMI
AF:
0.643
Gnomad AMR
AF:
0.539
Gnomad ASJ
AF:
0.438
Gnomad EAS
AF:
0.449
Gnomad SAS
AF:
0.578
Gnomad FIN
AF:
0.636
Gnomad MID
AF:
0.519
Gnomad NFE
AF:
0.546
Gnomad OTH
AF:
0.516
GnomAD4 exome
AF:
0.539
AC:
268799
AN:
498638
Hom.:
73840
Cov.:
6
AF XY:
0.540
AC XY:
139641
AN XY:
258644
show subpopulations
African (AFR)
AF:
0.524
AC:
6982
AN:
13330
American (AMR)
AF:
0.537
AC:
10119
AN:
18848
Ashkenazi Jewish (ASJ)
AF:
0.444
AC:
6207
AN:
13974
East Asian (EAS)
AF:
0.448
AC:
13945
AN:
31146
South Asian (SAS)
AF:
0.578
AC:
25172
AN:
43516
European-Finnish (FIN)
AF:
0.624
AC:
20274
AN:
32490
Middle Eastern (MID)
AF:
0.466
AC:
1309
AN:
2812
European-Non Finnish (NFE)
AF:
0.540
AC:
170069
AN:
314898
Other (OTH)
AF:
0.533
AC:
14722
AN:
27624
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
5732
11463
17195
22926
28658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1706
3412
5118
6824
8530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.541
AC:
82273
AN:
152018
Hom.:
22360
Cov.:
32
AF XY:
0.545
AC XY:
40493
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.524
AC:
21735
AN:
41450
American (AMR)
AF:
0.539
AC:
8233
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.438
AC:
1520
AN:
3470
East Asian (EAS)
AF:
0.450
AC:
2320
AN:
5160
South Asian (SAS)
AF:
0.577
AC:
2773
AN:
4808
European-Finnish (FIN)
AF:
0.636
AC:
6721
AN:
10560
Middle Eastern (MID)
AF:
0.537
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
0.546
AC:
37130
AN:
67982
Other (OTH)
AF:
0.520
AC:
1099
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1966
3932
5898
7864
9830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.541
Hom.:
2754
Bravo
AF:
0.530

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.6
DANN
Benign
0.73
PhyloP100
-0.069
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228685; hg19: chr16-83065965; COSMIC: COSV51817135; COSMIC: COSV51817135; API